These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22980)
61. Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials. Huang KY; Tseng PT; Wu YC; Tu YK; Stubbs B; Su KP; Matsuoka YJ; Hsu CW; Lin CH; Chen YW; Lin PY Sci Rep; 2021 Jan; 11(1):452. PubMed ID: 33432057 [TBL] [Abstract][Full Text] [Related]
62. The use of a longer pilocarpine in the management of chronic simple glaucoma. Magder H; Boyaner D Can J Ophthalmol; 1974 Jul; 9(3):285-8. PubMed ID: 4844580 [No Abstract] [Full Text] [Related]
63. Treatment of ocular hypertension with oral beta-adrenergic blocking agents. Pandolfi M; Ohrström A Acta Ophthalmol (Copenh); 1974; 52(4):464-7. PubMed ID: 4479320 [No Abstract] [Full Text] [Related]
64. Acute hemodynamic effects of five beta-adrenoceptor blocking agents in man: the significance of selectivity and intrinsic sympathomimetic activity. Lysbo Svendsen T; Trap-Jensen J; Bliddal J; Hartling O; McNair A Acta Med Scand Suppl; 1979; 625():26-30. PubMed ID: 34979 [No Abstract] [Full Text] [Related]
65. Topical adrenergic potentiators in primary open-angle glaucoma. Kitazawa Y Am J Ophthalmol; 1972 Oct; 74(4):588-93. PubMed ID: 4403873 [No Abstract] [Full Text] [Related]
66. Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension. Wettrell K; Wilke K; Pandolfi M Br J Ophthalmol; 1978 May; 62(5):292-5. PubMed ID: 350263 [TBL] [Abstract][Full Text] [Related]
67. Effect of beta-adrenergic agonists and antagonists on repeated tonometry and episcleral venous pressure. Wettrell K; Wilke K; Pandolfi M Exp Eye Res; 1977 Jun; 24(6):613-9. PubMed ID: 17542 [No Abstract] [Full Text] [Related]
71. Role of adrenergic mechanisms in development and therapy of open-angled glaucoma. Langham ME Proc R Soc Med; 1971 Jun; 64(6):622-8. PubMed ID: 4996937 [No Abstract] [Full Text] [Related]
72. Effect of DL- and D-propranolol on oscular tension in rabbits and patients. Vale J; Phillips CI Exp Eye Res; 1970 Jan; 9(1):82-90. PubMed ID: 4392108 [No Abstract] [Full Text] [Related]
73. Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone. Geyskes GG; Stutterheim A; Boer P; Mees EJ Eur J Clin Pharmacol; 1975 Dec; 9(2-3):85-90. PubMed ID: 786689 [TBL] [Abstract][Full Text] [Related]
74. Letter: Adrenergic-blocking drugs in hyperthyroidism. Distiller LA; Joffe BI; Seftel HC Ann Intern Med; 1973 Dec; 79(6):899-900. PubMed ID: 4148614 [No Abstract] [Full Text] [Related]
75. Topical propranolol and ocular tension in the human. Vale J; Gibbs AC; Phillips CI Br J Ophthalmol; 1972 Oct; 56(10):770-5. PubMed ID: 4607298 [No Abstract] [Full Text] [Related]
76. Intraocular pressure reduction during treatment with pilocarpine and systemic propranolol. A comparative double-masked study. Wettrell K Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1977 Sep; 204(1):1-7. PubMed ID: 335912 [TBL] [Abstract][Full Text] [Related]
77. A myth of ophthalmic beta-blockers therapy. Kittisupamongkol W Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1721; author reply 1723. PubMed ID: 19693528 [No Abstract] [Full Text] [Related]
78. Pilocarpine ocusert system for sustained control of ocular hypertension. Macoul KL; Pavan-Langston D Arch Ophthalmol; 1975 Aug; 93(8):587-90. PubMed ID: 1164218 [TBL] [Abstract][Full Text] [Related]